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mTORC1 promotes cell growth in response to nutri-
ents and growth factors. Insulin activates mTORC1
through the PI3K-Akt pathway, which inhibits the
TSC1-TSC2-TBC1D7 complex (the TSC complex)
to turn on Rheb, an essential activator of mTORC1.
However, the mechanistic basis of how this path-
way integrates with nutrient-sensing pathways is
unknown. We demonstrate that insulin stimulates
acute dissociation of the TSC complex from the lyso-
somal surface, where subpopulations of Rheb and
mTORC1 reside. The TSC complex associates with
the lysosome in a Rheb-dependent manner, and its
dissociation in response to insulin requires Akt-
mediated TSC2 phosphorylation. Loss of the PTEN
tumor suppressor results in constitutive activation
of mTORC1 through the Akt-dependent dissociation
of the TSC complex from the lysosome. These find-
ings provide a unifying mechanism by which inde-
pendent pathways affecting the spatial recruitment
of mTORC1 and the TSC complex to Rheb at the
lysosomal surface serve to integrate diverse growth
signals.INTRODUCTION
Cells within multicellular organisms simultaneously sense both
cell-autonomous and systemic growth signals in the form of
nutrients and endocrine factors. The ability to properly integrate
these signals is key to coordinating the growth of individual
cells with the needs of both the local cellular niche and the
whole organism. As such, the pathways sensing and relaying
the status of cellular growth conditions are frequently dysregu-
lated in common human diseases with underlying genetic and
environmental influences, including cancer and diabetes.The mechanistic target of rapamycin (mTOR) complex 1
(mTORC1) is a highly conserved regulator of cell growth and is
one of the most highly integrated signaling nodes present in all
cells (Dibble and Manning, 2013; Laplante and Sabatini, 2012).
mTORC1 is composed of the protein kinase mTOR in complex
with two other essential core components, Raptor and mLST8.
Upon activation, mTORC1 shifts the metabolic program of the
cell from catabolic metabolism to growth-promoting anabolic
metabolism, stimulating the synthesis of proteins, lipids, and
nucleotides (Howell et al., 2013). As the cellular processes
downstream of mTORC1 are costly with respect to the carbon,
nitrogen, oxygen, and ATP required, it is not surprising that cells
have evolved exquisite mechanisms by which the intracellular
availability of nutrients and energy influence the activation state
of mTORC1 (Dibble and Manning, 2013). In addition, mTORC1 is
regulated by a large variety of secreted factors, including growth
factors, cytokines, and hormones, such as insulin and insulin-like
growth factor 1 (IGF1), which relay systemic metabolic signals
and stimulate signaling cascades upstream of mTORC1. In
this manner, mTORC1 responds to diverse local and systemic
growth cues to control anabolic metabolism and the growth of
cells, tissues, and organisms.
The progress made in understanding how mTORC1 senses
these diverse signals stems from the discovery of two classes
of Ras-related small G proteins lying directly upstream of
mTORC1, the Rag, and Rheb GTPases. Rag proteins function
as a heterodimer of a RagA or B subunit complexed with a
RagC or D subunit and are required for mTORC1 to sense amino
acids (Kim et al., 2008; Sancak et al., 2008). The Rag heterodimer
is held at the lysosomal surface by a complex of proteins referred
to as the Ragulator (Sancak et al., 2010). Importantly, amino
acids influence the GTP/GDP-loading state of the RagA/B
subunit through the combined action of a GTPase-activating
protein (GAP) complex called GATOR1 (Bar-Peled et al., 2013)
and a guanine nucleotide exchange factor (GEF) activity inherent
to the Ragulator (Bar-Peled et al., 2012). In the presence of
amino acids, the RagA/B subunit is converted to its GTP-bound
form, and the Ragulator-Rag complex recruits mTORC1 to the
lysosomal surface through direct interactions between theCell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc. 771
Rag heterodimer and Raptor (Bar-Peled et al., 2012, 2013; Kim
et al., 2008; Sancak et al., 2008, 2010; Zoncu et al., 2011). This
dynamic regulation of mTORC1 localization by amino acid avail-
ability, although essential, is not sufficient for the activation of
mTORC1, which also requires the presence of Rheb (Sancak
et al., 2010). Rheb has been described to localize onmultiple en-
domembrane compartments, including the lysosome, and this is
believed to require the C-terminal farnesylation of Rheb (Buerger
et al., 2006; Clark et al., 1997; Saito et al., 2005; Sancak et al.,
2010; Takahashi et al., 2005). The GTP/GDP-loading state of
Rheb is controlled by the presence of secreted growth factors,
rather than amino acids, and GTP-bound Rheb is a potent and
essential direct activator of mTORC1 (Dibble and Manning,
2013).
Rheb is controlled by a complex of three core proteins—
referred to as the tuberous sclerosis complex (TSC) complex—
composed of the TSC tumor suppressors, TSC1 and TSC2,
and Tre2-Bub2-Cdc16-1 domain family member 7 (TBC1D7)
(Dibble and Manning, 2013). Within the TSC complex, TSC2
acts as a GAP for Rheb and TSC1 scaffolds TSC2 and TBC1D7
together and stabilizes these proteins. Through its Rheb-GAP
activity, the TSC complex is an essential inhibitor of mTORC1
signaling, and loss of any of the three components of the complex
results in growth-factor-independent activation of mTORC1.
Importantly, insulin and growth factors activatemTORC1 primar-
ily through the stimulation of a pathway involving class I phospha-
tidylinositol-3-kinase (PI3K) and its downstream effector Akt, a
protein kinase that directly phosphorylates multiple serine and
threonine residues on TSC2 within the TSC complex (Inoki
et al., 2002; Manning et al., 2002; Potter et al., 2002). The Akt-
mediated phosphorylation of all five mapped phosphorylation
sites on TSC2 appears to be required for maximal activation of
mTORC1 by insulin (Inoki et al., 2002; Zhang et al., 2009). There-
fore, insulin signaling negatively regulates the TSC complex to
promote the Rheb-dependent activation of mTORC1 (Figure 1A).
Despite the establishment of the TSC complex and Rheb as
the major signaling components regulating the activation state
of mTORC1 by growth factors (Figure 1A), the mechanistic basis
for this regulation remains poorly defined. It is widely believed
that TSC2 phosphorylation by Akt turns off its Rheb-GAP activ-
ity, but this has never been shown. Some studies and models
have suggested that insulin signaling inhibits the TSC complex
by causing disassembly of the complex (Cai et al., 2006; Inoki
et al., 2002; Potter et al., 2002), although this has not been
observed in other studies (Dong and Pan, 2004; Manning et al.,
2002). Additional studies have suggested that the Akt-mediated
phosphorylation of TSC2 causes its degradation (Dan et al.,
2002; Plas and Thompson, 2003). Finally, how the TSC com-
plex-Rheb circuit is spatially integrated with the recruitment of
mTORC1 to the lysosome by the Ragulator-Rag complex in
response to amino acids is unknown. Here, through the localiza-
tion of endogenous proteins, we demonstrate that the TSC com-
plex localizes to the lysosome in the absence of growth factors
and acutely dissociates from this location in response to insulin.
The lysosomal localization of the TSC complex requires farnesy-
lated Rheb, and the insulin-stimulated release of the TSC com-
plex from the lysosomal surface requires the Akt-mediated
phosphorylation of TSC2. Our data demonstrate that this spatial772 Cell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc.regulation of the TSC complex is independent of the spatial con-
trol of mTORC1 and provides a unifying mechanism by which
mTORC1 integrates diverse growth signals at the lysosome.
RESULTS
Insulin Signaling Does Not Influence TSC Complex
Stability or Block Its GAP Activity
To facilitate an investigation into the molecular nature of
signaling through the Akt-TSC complex-Rheb circuit, we first es-
tablished the dose-dependent and temporal nature of signaling
between Akt and mTORC1 in HeLa cells. We found that maximal
pathway activation occurs at 1 mM insulin (Figure S1A available
online) and that Akt is rapidly activated (< 1 min) with maximal
downstream phosphorylation of TSC2 occurring almost simulta-
neously (Figure 1B). Subsequent activation of mTORC1, as
monitored by phosphorylation of its classic substrates S6K1
and 4E-BP1, occurs several minutes later, reaching near
maximum at 15 min. Therefore, the mechanism through which
Akt acutely inhibits the TSC complex to activate Rheb and
mTORC1 must occur within this time frame.
Contradictory to previously proposed models (Cai et al., 2006;
Dan et al., 2002; Inoki et al., 2002; Plas and Thompson, 2003;
Potter et al., 2002), no effects of acute insulin stimulation on total
endogenous TSC2 levels or complex stability were detected,
even out to an hour of stimulation (Figures 1B–1E and S1B–
S1E). To assess effects on complex integrity, we immunopurified
TSC complexes from unstimulated or insulin-stimulated (15 min)
cells using antibodies to each component of the complex (Fig-
ure 1C) or from cells stimulatedwith a time course of insulin using
a second TSC1 antibody (Figure S1B). Regardless of the anti-
body used or time point, there was no change in the association
of complex components upon insulin stimulation. Additional im-
munoprecipitations with antibodies that only recognize TSC2
phosphorylated by Akt on either S939 or T1462 confirmed that
TSC1 and TBC1D7 readily associate with phosphorylated
TSC2 and remain stably bound even after an hour of insulin stim-
ulation (Figure 1D). We also failed to detect effects of insulin
signaling and TSC2 phosphorylation on TSC complex stability
in MEFs (Figures S1C and S1D). As a complementary approach
to assess effects on the TSC complex, including any higher-or-
der quaternary structure, we used size-exclusion chromatog-
raphy (Figure 1E). We previously showed, using density-gradient
fractionation, that loss of any of the three TSC complex compo-
nents results in a shift of the remaining subunits to fractions of
lower molecular mass (Dibble et al., 2012). Likewise, any effects
of insulin signaling on TSC complex integrity should be evident in
the shifting of complex components between fractions. In
serum-starved cells, TSC2, TSC1, and TBC1D7 cofractionated
with a peak mass of 2 MDa (as calculated from a standard
curve, Figure S1E), representing a complex that is considerably
larger than the predicted mass of a single heterotrimeric unit
(365 kDa). Consistent with our previous observations (Dibble
et al., 2012), all TSC1 species appear to be part of the TSC com-
plex, whereas smaller pools of both TSC2 and TBC1D7 exist that
are not part of the complex, with the TBC1D7 pool fractionating
near its predictedmass of34 kDa and the TSC2 pool running at
an apparent mass of 600 kDa. Importantly, in lysates from
Figure 1. Insulin Signaling Acutely Stimulates mTORC1 without Effects on TSC Complex Stability or a Block in Rheb-GAP Activity
(A) Schematic of the Akt-TSC complex-Rheb circuit through which insulin activates mTORC1.
(B) HeLa cells were serum starved and then stimulated with a time course of insulin.
(C and D) HeLa cells were serum starved and then stimulated with insulin (15 min) prior to lysis and immunoprecipitation with antibodies to TSC2, TSC1, and
TBC1D7 (C) or phospho-TSC2-T1462 and phospho-TSC2-S939 (D).
(E) Lysates from cells treated as in (C) were fractionated using size-exclusion chromatography. Estimated molecular weights (kDa) for fractions were calculated
from a standard curve (Figure S1E).
(F) Endogenous TSC complexes immunoprecipitated with a TSC1 antibody, or IgG control, from lysates of cells treated as in (C) were subjected to Rheb-GAP
assays using recombinant GST or GST-Rheb preloaded with GTP[a-32P]. Rheb-bound GTP and GDP were separated by thin-layer chromatography (TLC).
The percentage of conversion to GDP (GDP/GTP + GDP) is graphed as the mean of three independent experiments ± SEM. *p < 0.02 compared to TSC1
immunoprecipitation from unstimulated cells.
See also Figure S1.insulin-stimulated cells, TSC2 phosphorylation was largely
restricted to TSC2 within the TSC complex, and the fractionation
patterns of TSC complex components were identical to those
from unstimulated cells, indicating that higher-order complex
integrity was unaffected. As a control, we examined the fraction-
ation pattern of the mTORC1 components mTOR and Raptor,
which are known to loosen their intermolecular contacts uponactivation (Kim et al., 2002). We found that mTOR and Raptor
cofractionated at 1 MDa, which is consistent with mTORC1
forming a higher-order dimer (Wang et al., 2006; Yip et al.,
2010), and a subset of both mTOR and Raptor shifted to lower
molecular mass fractions upon insulin stimulation (Figure 1E).
Finally, we found that endogenous TSC complexes display a
small, but reproducible, decrease in Rheb-GAP activity whenCell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc. 773
(legend on next page)
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isolated from insulin-stimulated cells (Figure 1F). However, the
GAP activity of the TSC complex is largely intact upon insulin
stimulation. Therefore, using multiple independent approaches,
we establish that regulation of the TSC complex by insulin
does not involve even small effects on complex stability or the
turning off of its GAP activity, suggesting alternative inhibitory
mechanisms underlying the robust and rapid downstream
activation of mTORC1.
Insulin Activates mTORC1 by Inducing Dissociation
of the TSC Complex from the Lysosome
To determine whether insulin signaling might alter the spatial
distribution of the TSC complex, we localized endogenous
TSC2 with an antibody validated previously for immunofluores-
cence (Dibble et al., 2012). The primary localization of TSC2
under basal, serum-starved conditions was found to be at the
lysosomal surface, colocalizing with the lysosomal marker
LAMP2 (Figure 2A). The remainder of TSC2 localized diffusely
to punctate structures throughout the cytosol, exhibiting some
small overlap with Golgi (Figure S2A) and no discernable coloc-
alization with markers of either the mitochondria (Figure S2B) or
peroxisomes (Figures S2C and S2D). Strikingly, the extensive
TSC2-LAMP2 colocalization observed under serum starvation
conditions was acutely and significantly reduced in response
to insulin (Figure 2A, graphs; Figure S2E, immunoblots; and
Figure 2B, high-resolution confocal imaging). Consistent with
the dose response of the Akt-TSC complex-mTORC1 pathway
to insulin (Figure S1A), increasing doses of insulin stimulated
more dissociation of TSC2 from the LAMP2 compartment (Fig-
ure S2F). Furthermore, the SEM for TSC2-LAMP2 colocalization
decreased with increasing doses of insulin, indicating the sto-
chastic nature of this response. Hence, the dose dependency
of insulin signaling detected on immunoblots results from both
stronger responses within individual cells and more cells simul-
taneously responding with increasing insulin doses. A similar
reduction in TSC2-LAMP1 colocalization was observed upon
insulin stimulation in MEFs (Figure S2G). We also noted that
insulin stimulation led to a more dispersed cellular distribution
of lysosomes in both HeLa cells and MEFs, an effect described
previously (Korolchuk et al., 2011). To determine whether the
loss of TSC2 from its lysosomal localization is secondary to
effects on lysosome clustering, we used nocodazole to physi-
cally disperse the lysosomes by disrupting the microtubule
cytoskeleton (Figures S2H and S2I). Unlike insulin stimulation,
TSC2-LAMP2 colocalization was unaffected by nocodazole-Figure 2. Insulin Acutely Disrupts the Lysosomal Localization of the T
(A) HeLa cells were serum starved and then stimulated with a time course of insu
(green). Representative cells are shown where yellow or orange pixels indicate
correlation coefficient (PCC) are graphed as a mean ± SEM (right). *p < 13 106
(B) Cells were treated and labeled as in (A)—but with a single 15 min insulin
LAMP2-containing compartment from the bottom cells in the two images is show
(% colocalization) and *p < 1 3 1010 (PCC) compared to unstimulated (0 min).
(C) HeLa cells stably expressing a control shRNA (shGFP) or one targeting TBC1D
(green). Representative cells are shown, and percent colocalization is presented
(D) Cells treated as in (B) were labeled for TSC2 (red) and TBC1D7 (green), with
(E) Cells were treated as in (B), and lysates were separated into heavy membran
See also Figure S2.induced dispersion of the lysosomes. To determine whether it
is the entire TSC complex that is being spatially regulated in
this manner, we validated (via shRNA knockdown) a TBC1D7
antibody for immunofluorescence and found that, under serum
starvation conditions, a large subpopulation of endogenous
TBC1D7 also colocalizes with LAMP1 (Figure 2C). Like TSC2,
insulin stimulation acutely reduced the lysosomal localization
of TBC1D7. However, insulin did not affect the colocalization
of TBC1D7 with TSC2 (Figure 2D), which is consistent with the
fact that their association, which is mediated through their inter-
actions with TSC1 (Dibble et al., 2012), is unaffected by insulin
(Figures 1C–1E and S1B–S1E). Finally, in lysates of cells stimu-
lated with insulin for 15 min, both TSC1 and TSC2 levels were
reduced in the heavy membrane fraction containing lysosomes,
with a concomitant increase in the fraction containing cytosolic
and light membrane compartments (Figure 2E), further indicating
that it is the intact TSC complex that acutely dissociates from
the lysosomal surface in response to insulin.
Taken together with studies demonstrating the importance of
lysosomal localization for mTORC1 activation, the above find-
ings suggest that the insulin-stimulated dissociation of the
TSC complex from the lysosome could represent a mechanism
by which insulin signaling activates mTORC1. To further test
this idea, we tethered TSC2 to the lysosomal surface through
a fusion with the amino terminus of p18/LAMTOR1 (Lyso-
TSC2; Figure 3A), which localizes the Ragulator complex to
the lysosome through myristoylation and palmitoylation moi-
eties (Nada et al., 2009; Sancak et al., 2010). Lyso-TSC2 was
indistinguishable from wild-type TSC2 in its ability to assemble
into the TSC complex (Figure S3A). The constitutive lysosomal
localization of this fusion protein was confirmed in Tsc2/
MEFs, in which insulin induced the release of exogenously
expressed wild-type TSC2, but not Lyso-TSC2, from the lyso-
some (Figure 3B). Importantly, unlike in wild-type TSC2-ex-
pressing cells, insulin failed to stimulate the phosphorylation
of T389 on coexpressed S6K1 in the Lyso-TSC2-expressing
cells, despite similar phosphorylation of wild-type and Lyso-
TSC2 (Figure 3C). Exogenous expression of Lyso-TSC2, but
not wild-type TSC2, also attenuated mTORC1 signaling to
both endogenous and coexpressed S6K1 in 293E cells grown
in full serum (Figures S3B–S3D) and suppressed the insulin-
stimulated phosphorylation of S6K1 (Figure 3D). Therefore,
the ability of growth factors to induce dissociation of the TSC
complex from the lysosomal surface is required for the proper
stimulation of mTORC1 signaling.SC Complex
lin prior to immunofluorescent labeling of endogenous TSC2 (red) and LAMP2
colocalization in the merged images. Percent colocalization and Pearson’s
(% colocalization) and *p < 13 1012 (PCC) compared to unstimulated (0 min).
stimulation—and imaged by confocal microscopy. An enlarged view of the
n below. Percent colocalization and PCC are presented as in (A). *p < 13 1013
7 (shTBC1D7) were treated as in (B) and labeled for TBC1D7 (red) and LAMP1
as in (A). *p < 1 3 1010.
percent colocalization presented as in (A).
e and light membrane/cytosolic fractions.
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Figure 3. Forced Targeting of TSC2 to the
Lysosome Suppresses Insulin-Stimulated
mTORC1 Signaling
(A) Schematic of FLAG-tagged WT-TSC2 and
Lyso-TSC2, a fusion of TSC2 with the lysosome-
targeting signal of p18/LAMTOR1.
(B) Tsc2/ MEFs were infected with lentiviruses
encoding WT-TSC2 or Lyso-TSC2 and were
serum starved and then insulin stimulated (15min).
Representative TSC2-expressing cells are shown
colabeled for TSC2 (red) and LAMP1 (green).
Percent colocalization is graphed as the mean ±
SEM (below). *p < 1 3 1012 compared to
unstimulated WT-TSC2.
(C) WT-TSC2 or Lyso-TSC2 was cotransfected
with HA-S6K1 in Tsc2/MEFs, followed by serum
starvation and insulin stimulation (100 nM, 15 min).
Phosphorylation of the HA-S6K1 reporter was
detected in anti-HA immunoprecipitates, and the
relative ratios of phospho-S6K1 to total S6K1 are
shown normalized to unstimulatedWT-TSC2 cells.
(D) 293E cells were cotransfected with empty
vector (vec), WT-TSC2, or Lyso-TSC2 and HA-
S6K1 and were treated and analyzed as in (C), with
relative phospho-S6K1 levels normalized to the
unstimulated vector cells.
See also Figure S3.Insulin and Amino Acids Independently Regulate
Localization of the TSC Complex and mTORC1
to the Lysosome and Rheb
Neither amino acids nor insulin alone are sufficient to robustly
stimulate mTORC1 (Hara et al., 1998) (Figure 4A). To understand
the relationship between these signals and the spatial regula-
tion of both mTORC1 and the TSC complex to the lysosomal
surface, we compared the parallel effects of acute insulin
or amino acid stimulation. As described previously (Sancak
et al., 2010; Zoncu et al., 2011), the population of mTOR at776 Cell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc.the lysosome represents mTORC1, as
mTOR-LAMP2 colocalization is lost
upon knockdown of Raptor (data not
shown). Unlike TSC2, the colocalization
of mTOR with LAMP2 was unaffected
by insulin stimulation (Figures 4B and
S4A). The insulin-stimulated release of
TSC2 from the LAMP2 compartment
was similar in the presence (Figures 4B
and S4A) or absence (Figure 4C) of amino
acids. As anticipated, mTOR translo-
cated to the lysosome within 10 min of
refeeding cells with amino acids in either
the absence (Figure 4D) or presence
(Figure 4E) of serum. In contrast, the
lysosomal localization of TSC2 was
unaffected by amino acid starvation and
acute refeeding under these conditions
(Figures 4D and 4E). Therefore, acute
signals from amino acids and insulin
independently and reciprocally regulatethe association of mTORC1 and the TSC complex with the
lysosome.
As the TSC complex regulates mTORC1 through Rheb, we
sought to characterize the subcellular localization of endoge-
nous Rheb. A Rheb antibody for which the immunostaining
pattern was abolished upon small interfering RNA (siRNA)-medi-
ated knockdown of Rheb1 and Rheb2/RhebL1 was identified
(Figure 5A). Under serum starvation conditions, endogenous
Rheb was detected as punctate labeling throughout the
cell with concentrated labeling in a perinuclear region that
Figure 4. Independent Effects of Amino Acids and Insulin on Localization of mTORC1 and the TSC Complex to the Lysosome
(A) HeLa cells were grown in the absence (ss) or presence of dialyzed serum (dFBS) and then starved of all amino acids (50 min) prior to stimulation with insulin
(15 min), amino acids (10 min), or insulin (15 min) plus amino acids (final 10 min). Light and dark exposures are shown for phospho-S6K1.
(B) HeLa cells were serum starved and stimulated with insulin (15 min) prior to immunofluorescent colabeling of TSC2 or mTOR with LAMP2 (images shown in
Figure S4A). Percent colocalization is graphed as the mean ± SEM. *p < 1 3 1011.
(C) Cells starved of serum (16 hr) and amino acids (50 min) were stimulated with insulin (15 min) prior to colabeling of TSC2 (red) and LAMP2 (green) and
quantification of colocalization as in (B) (graph at right). *p < 1 3 1011.
(D) Cells starved of serum (16 hr) and amino acids (50 min) were stimulated with amino acids (10 min) prior to labeling and quantification of colocalization as in (B)
*p < 1 3 108.
(E) HeLa cells grown in 10% dFBS (16 hr) and starved of amino acids (50 min) were stimulated with amino acids (10 min) prior to labeling and quantification of
colocalization as in (B). *p < 1 3 108.
See also Figure S4.colocalized with LAMP1, indicating that, like mTOR and TSC2,
a subset of endogenous Rheb localizes to the lysosome. The
lysosomal localization of Rheb requires membrane anchoringthrough its C-terminal farnesyl group, as a farnesyl-transferase
inhibitor (FTI) disrupted the Rheb-LAMP1 colocalization (Fig-
ure 5A). The effects of FTI treatment on Rheb farnesylationCell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc. 777
Figure 5. A Subpopulation of Rheb Localizes to the Lysosome, Where Its Colocalization with the TSC Complex andmTORC1 Is Respectively
Regulated by Insulin and Amino Acids
(A) HeLa cells with siRNA-mediated knockdown of Rheb1 and 2, or control siRNAs, were serum starved (16 hr) with or without FTI-277 (10 mM) prior to colabeling
of Rheb1 (red) and LAMP1 (green). Representative cells are shown, along with an immunoblot of parallel lysates (right) showing effects on Rheb levels and
modification (farnesylated [F] and unfarnesylated [UF]), and the percent colocalization is graphed as mean ± SEM. *p < 1 3 107.
(B) HeLa cells starved of serum (16 hr) and amino acids (50 min) were stimulated with amino acids (10 min) prior to colabeling of Rheb1 and LAMP1 (images
in Figure S5A). The percent colocalization is graphed as in (A).
(C)Cellswereserumstarvedand thenstimulatedwith insulin (15min) prior tocolabelingas in (B) (images inFigureS5B).Thepercentcolocalization isgraphedas in (A).
(D) Cells were treated as in (B) prior to colabeling of mTOR or TSC2 (red) and Rheb1 (green). Representative cells are shown, and the percent colocalization
is graphed as in (A). *p < 1 3 109.
(E) Cells were treated as in (C) prior to the labeling and analysis described in (D). *p < 1 3 109.
See also Figure S5.
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were evident by a decrease in Rheb mobility in SDS-PAGE,
indicating that nearly all cellular Rheb was farnesylated, and
following FTI treatment, 90% of Rheb became unfarnesylated
(Figure 5A, blot).
To determine whether the lysosomal localization of Rheb, like
that of mTORC1 and the TSC complex, is dynamically regulated,
we examined the effects of amino acid and insulin stimulation.
Neither amino acid starvation and refeeding (Figures 5B and
S5A) nor growth factor withdrawal followed by acute insulin stim-
ulation (Figures 5C and S5B in HeLa and Figure S5C in MEFs)
influenced the colocalization of Rheb and LAMP1. Therefore,
the lysosomal localization of Rheb is stable and not influenced
by cellular growth conditions that alter the activation state of
mTORC1. Consistent with the independent spatial regulation of
mTORC1 and the TSC complex at the lysosome, described
above, acute amino acid stimulation greatly increased mTOR-
Rheb colocalization but left TSC2-Rheb colocalization unaf-
fected (Figure 5D), whereas acute insulin stimulation had no
effect on mTOR-Rheb colocalization but greatly diminished
TSC2-Rheb colocalization (Figures 5E and S5D for confocal
image). These results indicate that converging signals from
amino acids and insulin differentially influence the binding and
release of mTORC1, the downstream effector of Rheb, and the
TSC complex, the upstream regulator of Rheb, from the lyso-
somal surface where a subpopulation of Rheb resides.
Rheb Is Required for Localization of the TSC Complex,
but Not mTORC1, to the Lysosome
As Rheb is the only protein at the lysosome known to interact
with TSC2, we determined whether it was involved in the lyso-
somal localization of the TSC complex. Upon siRNA-mediated
knockdown of Rheb, the insulin-stimulated activation of Akt
and its phosphorylation of TSC2 were unaffected, but the
expected decrease in mTORC1 signaling was observed (Fig-
ure 6A). Interestingly, the perinuclear clustering of TSC2 and
its pronounced colocalization with LAMP2, typical of serum-
starved cells, was disrupted upon Rheb knockdown, resulting
in TSC2 localization that resembled the insulin-stimulated state
(Figure 6B). This effect was specific to the TSC complex, as
mTOR-LAMP2 colocalization was unaffected by Rheb depletion
(Figures 6C and S6A). Dissociation of Rheb from the lysosomal
membrane by FTI treatment also decreased TSC2-LAMP2
colocalization without effects on Akt activation or TSC2 phos-
phorylation (Figures 6D and 6E). Consistent with the pre-
dominant interactions between the TSC complex and Rheb
occurring on the lysosomal surface, FTI treatment also greatly
reduced TSC2-Rheb colocalization (Figures 6F and S6B). Asso-
ciation of mTORC1 with the lysosome was not affected by FTI
treatment (Figures 6G and S6C), although loss of Rheb from
the lysosome was reflected in a decrease in mTOR-Rheb coloc-
alization (Figures 6H and S6D). Therefore, the ability of the TSC
complex to associate with the lysosome under growth factor
withdrawal conditions is dependent upon Rheb and its proper
membrane anchoring, whereas the lysosomal localization of
mTORC1 is independent of Rheb.
To further characterize the molecular nature of the interaction
between Rheb and the TSC complex, we determined how the
nucleotide-binding state of Rheb influenced this interaction.Interestingly, we found that the endogenous TSC complex binds
most strongly to the GDP-loaded form of Rheb (Figure 6I), a
property unusual among Ras family GAPs (see Discussion).
This binding was dependent on TSC2 (Figure S6E) and sensitive
to insulin stimulation, which weakened the ability of endogenous
TSC complexes to bind both GDP- and GTP-bound Rheb (Fig-
ure 6J). These data suggest that a regulated interaction with
Rheb contributes to the spatial control of the TSC complex.
The PI3K-Akt Pathway Induces Dissociation of the TSC
Complex from the Lysosome through Phosphorylation
of TSC2
In response to insulin, the direct phosphorylation of TSC2 by
Akt occurs in the same acute fashion as dissociation of the
TSC complex from the lysosome (see Figures 1B, 2A, S2E, and
S2G), suggesting involvement of this modification in the
spatial regulation of the complex. Brief pretreatment of cells
with the PI3K inhibitor wortmannin or the Akt-specific inhibitor
MK2206 completely blocked insulin-stimulated Akt activation,
TSC2 phosphorylation, and mTORC1 signaling in both HeLa
cells and MEFs (Figures 7A and S7A). Importantly, this loss of
insulin-stimulated mTORC1 signaling coincided with an inability
of insulin to induce the dissociation of TSC2 from the lysosome in
these cells (Figures 7B and S7B). Likewise, the insulin-induced
movement of TSC1 and TSC2 from heavy membrane fractions
to those containing cytosol and light membranes was blocked
by Akt inhibition (Figure 7C). The weakened association of
the TSC complex with recombinant Rheb-GDP upon insulin
stimulation was also attenuated by inhibition of Akt (Figure S7C).
Previous studies in wild-type (Inoki et al., 2002) or Tsc2 null
(Zhang et al., 2009) cells have indicated that phosphorylation
of all five Akt-targeted residues on TSC2 is required for full
activation of mTORC1 signaling in response to insulin. To test
the role of these phosphorylation events in the spatial regula-
tion of the TSC complex, we reconstituted Tsc2 null MEFs with
wild-type TSC2 (TSC2-WT) or TSC2 lacking these five phos-
phoacceptor sites (TSC2-5A). In TSC2-WT-expressing cells,
the growth-factor-independent activation of mTORC1 signaling
was blocked, and its sensitivity to insulin was restored (Fig-
ure 7D). In TSC2-5A-expressing cells, the constitutive activation
of mTORC1 was similarly blocked, but mTORC1 signaling
became unresponsive to insulin, despite proper activation of
Akt and signaling to other Akt targets, such as PRAS40. Consis-
tent with the proper suppression of mTORC1 signaling in the
absence of growth factors, a similar percentage of TSC2-WT
and TSC2-5A was found to associate with the lysosome under
serum starvation conditions (Figure 7E). As with endogenous
TSC2 in wild-type MEFs (Figure S2G), the lysosomal localization
of TSC2-WT was disrupted by insulin stimulation. However,
TSC2-5A association with the lysosome remained unchanged
upon insulin stimulation (Figure 7E). To further examine effects
of the Akt sites on TSC2 for dissociation of the TSC complex
from the lysosomal surface, we immunopurified TSC2-asso-
ciated complexes from reconstituted Tsc2/ cells that were
lysed in the presence of a crosslinking agent. Consistent with
our immunofluorescence findings, insulin stimulated release of
TSC2-WT, but not TSC2-5A, from the compartment containing
LAMP1 (Figure 7F). It is worth noting that we do not detectCell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc. 779
Figure 6. Localization of the TSC Complex, but Not mTORC1, to the Lysosome Is Dependent on Farnesylated Rheb
(A) HeLa cells with siRNA-mediated knockdown of Rheb1 and 2, or control siRNAs (siC), were serum starved and then stimulated with insulin (100 nM, 15 min).
Note: the siC and siRheb1/2 samples are from the same blot and exposure.
(B) Cells treated as in (A) were colabeled for TSC2 (red) and LAMP2 (green). Representative cells are shown, and percent colocalization is graphed asmean ±SEM
(right). *p < 1 3 1012 for comparison with unstimulated siC cells.
(C) Cells treated as in (A) were colabeled for mTOR and LAMP2 (images in Figure S6A) and quantified as in (B).
(legend continued on next page)
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association of the TSC complex with LAMP1 or 2 under standard
lysis conditions, suggesting lack of a direct interaction with these
lysosomal membrane proteins. These data demonstrate that the
insulin-induced dissociation of the TSC complex from the lyso-
some and subsequent Rheb-dependent activation of mTORC1
requires the phosphorylation of TSC2 by Akt, thereby providing
a mechanism of TSC complex inhibition by the PI3K-Akt
pathway.
The PI3K-Akt pathway is frequently activated in human can-
cers, and this commonly occurs through loss of the PTEN tumor
suppressor. Consistent with constitutive PI3K signaling, PTEN-
deficient prostate cancer cells (PC3, Figure 7G) and MEFs (Fig-
ure S7D) displayed growth-factor-independent activation of
Akt, phosphorylation of TSC2, andmTORC1 activation, signaling
events that were completely blocked by Akt inhibition. Impor-
tantly, these cells displayed dissociation of TSC2 from the
lysosome even under serum starvation conditions, and Akt
inhibition led to rapid translocation of TSC2 to the lysosome,
demonstrating the acutely reversible nature of this regulation
(Figures 7H and S7E). Therefore, in addition to physiological
stimuli, common pathological mutations leading to growth-fac-
tor-independent activation of the PI3K-Akt pathway in cancer
induce mTORC1 signaling through dissociation of the TSC com-
plex from the lysosomal surface.
DISCUSSION
Signals from amino acids and growth factors are both necessary,
but not sufficient, for full activation of mTORC1 (Dibble and
Manning, 2013; Hara et al., 1998; Laplante and Sabatini, 2012).
Our findings suggest a unifyingmodel for integrated coregulation
of mTORC1 by these inputs (Figure 7I). It has been established
that the amino acid signal through the Ragulator and Rag pro-
teins serves to localize mTORC1 to the lysosomewithout directly
stimulating its activation (Kim et al., 2008; Sancak et al., 2008,
2010). Localization of mTORC1 to the lysosome brings it into
proximity with its essential activator Rheb (Sancak et al., 2010),
which, in its GTP-bound form, can directly stimulate mTORC1
kinase activity (Sancak et al., 2007). Previous studies have
localized exogenously expressed Rheb fusion proteins to endo-
membrane compartments, including the ER, Golgi, and lyso-
somes (Buerger et al., 2006; Clark et al., 1997; Saito et al.,
2005; Sancak et al., 2010; Takahashi et al., 2005). We find that
a subpopulation of endogenous Rheb does indeed localize—(D) HeLa cells serum starved (16 hr) with or without FTI-277 (FTI; 10 mM) were le
(E) Cells were treated as in (D) prior to labeling and quantification of colocalization
starved cells.
(F) Cells treated as in (D) were colabeled for TSC2 and Rheb1 (images in Figure S
untreated cells.
(G) Cells treated as in (D) were colabeled for mTOR and LAMP2 (images in Figur
(H) Cells treated as in (D) were colabeled for mTOR and Rheb1 (images in Figure S
untreated cells.
(I) Endogenous TSC complex components were pulled down from lysates of se
no nucleotide, GTPgS, or GDPbS compared to control pull-downs with GST or
with Ponceau S stain.
(J) GST-Rheb pull-downs were performed as in (I), but cells were stimulated with
See also Figure S6.through its farnesyl lipid modification—to the same LAMP1/2-
containing compartment as mTORC1, and this localization is
unaffected by amino acids or insulin. The only currently estab-
lished direct regulator of Rheb is the TSC complex, which we
find localizes to the lysosome in the absence of growth factors,
at least in part, through its association with Rheb. In contrast
to previous studies using the isolated GAP domain of TSC2
(Castro et al., 2003; Long et al., 2005), we found that endogenous
TSC2 within the intact TSC complex has a strong binding pre-
ference for Rheb-GDP, a property that is atypical for GAP
proteins, which normally bind preferentially to the GTP-bound
or transition states of their small G protein targets (Bos et al.,
2007; Chen et al., 2011; Daumke et al., 2004). Our data are
consistent with amodel in which, under growth factor withdrawal
conditions, the TSC complex stimulates the intrinsic GTPase
activity of Rheb on the lysosomal surface and, through the
conversion to Rheb-GDP, creates a strong binding partner that
holds the complex at this location. Whether the TSC complex
also acts as a guanine nucleotide dissociation inhibitor (or GDI)
in this state, thereby preventing nucleotide exchange on Rheb,
will be interesting to explore in future studies. Such a model
would also help explain the rapid accumulation of the TSC com-
plex at the lysosome and inhibition of mTORC1 signaling that we
observe upon inhibition of the PI3K-Akt pathway. We show that
insulin acutely stimulates dissociation of the TSC complex from
Rheb at the lysosomal surface and that this requires the direct
phosphorylation of TSC2 by Akt. This induced release of the
TSC complex from lysosomal Rheb allows Rheb-GTP loading
and is required for the proper activation of mTORC1 by insulin.
In contrast to previously suggested models (Cai et al., 2006;
Dan et al., 2002; Inoki et al., 2002; Plas and Thompson, 2003;
Potter et al., 2002), we demonstrate through a variety of
biochemical and immunofluorescence assays with endogenous
TSC complexes that acute insulin stimulation has no effect on
TSC complex integrity within the time frame in which mTORC1
is fully activated. It remains possible that there are longer-term
effects of growth factors on complex assembly or stability. How-
ever, such effects have not been detected in time courses out
to 12 hr of stimulation (Manning et al., 2002) and cannot underlie
the rapid Akt-dependent activation of mTORC1 by insulin and
other growth factors. In our biochemical characterization of the
TSC complex, we found the endogenous complex to be an esti-
mated 2 MDa in size, which is much larger than the predicted
mass of a single TSC1-TSC2-TBC1D7 unit (365 kDa) but is inft unstimulated or were stimulated with insulin (15 min).
as in (B) (graph to right). *p < 13 1010 for comparison with untreated, serum-
6B). Colocalization was quantified as in (B). *p < 1 3 109 for comparison with
e S6C). Colocalization was quantified as in (B).
6D). Colocalization was quantified as in (B). *p < 13 108 for comparison with
rum-starved HeLa cells with recombinant purified GST-Rheb preloaded with
GST-Rab5A preloaded with GDPbS. GST-fused bait proteins were detected
insulin (15 min).
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Figure 7. Akt-Mediated Phosphorylation of TSC2 Results in Dissociation of the TSC Complex from the Lysosome in Response to Insulin or
PTEN Loss
(A) Serum-starved HeLa cells were pretreated (30 min) with vehicle (DMSO), wortmannin (100 nM), or MK2206 (2 mM) and then stimulated with insulin (15 min).
(B) Cells treated as in (A) were colabeled for TSC2 (red) and LAMP2 (green). Representative cells are shown, and the percent colocalization is graphed as amean ±
SEM. *p < 1 3 108 for comparison with insulin stimulation in vehicle-treated cells.
(legend continued on next page)
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agreement with evidence of multiple TSC1 and TSC2 subunits
within the quaternary structure (Hoogeveen-Westerveld et al.,
2012b). This size is consistent with the heterotrimeric unit, which
we fail to detect in cell lysates, perhaps forming a higher-order
pentameric structure with five of each component. Coincidently,
pentameric arrangements were observed in recent crystal struc-
tures of the N-terminal domain of yeast TSC1 (Sun et al., 2013).
Another misconception about TSC complex regulation was
that growth factor signaling acts primarily through inhibitory ef-
fects on the GAP activity of TSC2. GAP assays on endogenous
TSC complexes did indeed reveal a minor, but significant and
reproducible, reduction in GAP activity of complexes from insu-
lin-stimulated cells. However, following insulin stimulation, the
GAP activity of the TSC complex is largely intact, indicating
that phosphorylation of TSC2 on Akt-targeted sites does not
constitute an on/off switch for its GAP activity. As we found
that insulin and Akt signaling weaken the ability of the TSC com-
plex to associate with Rheb even in a cell-free system, the slight
decrease in GAP activity measured in these assays might reflect
this decreased binding efficiency. Akt signaling exerts a stronger
effect on release of the TSC complex from Rheb and the lyso-
somes in intact cells, suggesting that more complex physical
interactions are involved in this spatial regulation. Given our
data that the TSC complex exists as a large oligomeric structure,
it seems likely that the higher-order complex interacts with mul-
tiple Rheb proteins on the lysosomal surface simultaneously
and, perhaps, cooperatively. Although we find that Rheb is
required for the lysosomal localization of the TSC complex, it is
possible that interactions with other lysosomal surface proteins
or lipids also contribute to this localization and regulated release.
Currently, the organizational structure of the TSC complex is
completely unknown, but it is worth noting that, in the primary
structure of TSC2, the five Akt phosphorylation sites lie outside
of its GAP domain. Structural information on how the domains
of the three proteins are spatially positionedwithin the oligomeric
complex is required to understand themolecular contributions of
the individual Akt phosphorylation sites, and other regulatory
sites, to disrupting the binding interactions with Rheb and
possibly other constituents of the lysosomal membrane.
A vast network of oncogenes and tumor suppressors lies
upstream of mTORC1, and its activation is common in genetic
tumor syndromes and sporadic cancers (Menon and Manning,
2008). Although loss-of-function mutations in GATOR1, up-
stream of the Rag GTPases (Bar-Peled et al., 2013), can
contribute to tumorigenesis, the majority of genetic events lead-
ing to aberrant activation of mTORC1 in human tumors either
directly or indirectly affect the TSC complex. TSC1 and TSC2(C) Cells were treated as in (A), and lysates were separated into heavy membran
(D) Tsc2/MEFs expressing empty vector (V), wild-type TSC2 (WT), or the Akt-ph
insulin (15 min).
(E) Tsc2/MEFs were treated as in (D) prior to colabeling for reconstituted TSC2
*p < 1 3 108 for comparison with insulin-stimulated, TSC2-WT-expressing cells
(F) Tsc2/MEFs reconstituted with wild-type TSC2 (WT) or mutant TSC2 (5A) w
followed by immunoprecipitation with protein A/G agarose alone (C) or with TSC
(G) Serum-starved (16 hr) PC3 cells were treated (30 min) with vehicle (DMSO) o
(H) PC3 cells were treated as in (G) prior to colabeling for TSC2 (red) and LAMP2
(I) Model of the spatial regulation of mTORC1 and the TSC complex at the lysos
See also Figure S7.are themselves tumor suppressors that, although more rarely
mutated in sporadic cancers, are disrupted in the cancer-like
syndromes TSC and lymphangioleiomyomatosis (LAM), which
are characterized by widespread tumors exhibiting elevated
mTORC1 signaling (Crino et al., 2006). Additionally, loss of
TBC1D7 gives rise to a megalencephaly syndrome accompa-
nied by increased mTORC1 signaling (Capo-Chichi et al.,
2013). In TSC and LAM patients, more than one hundred distinct
missense mutations or in-frame deletions have been identified in
TSC2 alone (Hoogeveen-Westerveld et al., 2012a; Hoogeveen-
Westerveld et al., 2013; Nellist et al., 2005). It seems likely that
the pathogenic mutations that do not affect TSC complex stabil-
ity or GAP activity might influence proper localization of the
complex to the lysosomal surface, where it regulates Rheb.
In the majority of sporadic cancers with elevated mTORC1
signaling, frequently activated oncogenic signaling pathways,
such as the PI3K-Akt pathway, activate mTORC1, at least in
part, by promoting constitutive dissociation of the TSC complex
from the lysosome. Reciprocally, pharmacological compounds
targeting these upstream pathways would drive the TSC com-
plex to Rheb at the lysosome and inhibit mTORC1 activation.
The recognition of this spatial regulation as a major mecha-
nism of control over the TSC complex and Rheb provides a valu-
able tool for characterizing the mechanistic basis for newly
identified upstream regulators, mutations, or compounds found
to influence mTORC1 signaling. In this context, investigators
can take advantage of the independent mechanisms affecting
the translocation of mTORC1 and the TSC complex to Rheb
at the lysosome. Altered lysosomal localization of mTOR would
indicate effects on the Ragulator-Rag branch, whereas altered
localization of TSC2 would indicate effects upstream of the
TSC complex or on Rheb itself. For instance, decreases in
cellular ATP levels inhibit mTORC1 signaling through a variety
of independent pathways, including those involving AMPK
(Dibble and Manning, 2013). We found that the widely used
AMPK-activating compound, A769662 (Cool et al., 2006),
blocks the insulin-stimulated dissociation of the TSC complex
from the lysosome and inhibits mTORC1 activation without ef-
fects on mTOR localization (data not shown). However, using
cells with knockout or knockdown of AMPKa1 and a2, we
were surprised to find that the effects of this compound on
mTORC1 signaling are independent of AMPK. Interestingly,
a recent study suggested that eccentric muscle contractions
activate mTORC1 and that this correlates with a decrease in
the colocalization of TSC2 and LAMP2 in mouse tissue sections
(Jacobs et al., 2013). Although our data indicate that neither
amino acid deprivation nor refeeding result in quantitativee and light membrane/cytosolic fractions.
osphorylation-site mutant of TSC2 (5A) were serum starved and stimulatedwith
(red) and endogenous LAMP1 (green). Colocalization was quantified as in (B).
.
ere treated as in (D) prior to lysis in hypotonic buffer with chemical crosslinking
2 antibody.
r MK2206 (2 mM).
(green). Colocalization was quantified as in (B). *p < 1 3 1010.
ome. See Discussion for details.
Cell 156, 771–785, February 13, 2014 ª2014 Elsevier Inc. 783
differences in TSC complex localization or its insulin-stimulated
dissociation from the lysosome, it is worth noting that an
accompanying study in this issue of Cell suggests that amino
acids can influence the lysosomal localization of TSC2 (Deme-
triades et al., 2014). The reason for these discrepant findings
is currently unknown, but in interpreting these localization
studies, it will be important to assess effects on established
signaling pathways upstream of the TSC complex (e.g., Akt
and AMPK) under the experimental conditions used in this other
study. Future studies will undoubtedly provide further details
regarding molecular crosstalk between the Ragulator-Rag and
TSC-Rheb circuits in the integrated regulation of mTORC1.
Finally, our findings suggest that spatial regulation of GAP
proteins may be a general control mechanism for other classes
of small G proteins, where the GAP proteins are acutely regu-
lated by phosphorylation without known effects on GAP activity,
including some other direct targets of Akt (Chen et al., 2011;
Mıˆinea et al., 2005).
EXPERIMENTAL PROCEDURES
Cell Culture
Cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) with
10% fetal bovine serum (FBS). For amino acid stimulation experiments,
subconfluent cells were starved for 50 min in DMEM lacking all amino acids,
with or without 10% dialyzed FBS (dFBS), followed by replacement with either
fresh amino-acid-free DMEM or standard DMEM for 10 min, with or without
dFBS. For insulin stimulation, subconfluent cells were serum starved in
DMEM (16 hr) and stimulated with 1 mM insulin for 15 min, unless otherwise
noted. Further details on cell lines and reagents are provided in the Extended
Experimental Procedures.
Immunofluorescence
Cells grown on glass coverslips were fixed with 4% paraformaldehyde, per-
meabilized with 0.2% Triton x-100, and blocked with Odyssey blocking
buffer, all in PBS. Coverslips were incubated with primary antibody overnight
at 4C, incubated with labeled secondary antibodies for 1 hr at room temper-
ature, and mounted. Images were acquired through 633 or 403 oil immer-
sion objectives with either a Zeiss Axiotome fluorescence microscope
with Apotome feature engaged or a Zeiss LSM 510META confocal laser
microscope. Representative cells are shown in all figures at the same expo-
sure and magnification. Quantitative analyses were done using Axiovision
(for pseudoconfocal images) or Volocity (for confocal images) software,
with calculation of thresholded Pearson’s correlation coefficients and coloc-
alization percentages. The latter is derived from the number of pixels in the
red channel that overlap with pixels from the green channel divided by the
total number of pixels detected in the red channel above the threshold value
(3 100). Identical settings were used to capture images across five separate
fields (25 to 50 cells) per condition, with the data presented being repre-
sentative of at least two independent experiments. Antibody details and
methods for image acquisition and analyses are provided in the Extended
Experimental Procedures.
DNA Constructs, RNAi, and Biochemical Analyses
Details regarding all constructs and RNAi reagents and their introduction
into cells, antibodies used for immunoblotting and immunoprecipitation, and
detailed biochemical methods are provided in the Extended Experimental
Procedures.
Statistics
Data are expressed asmean ±SEM. Significance of differences in GAP assays
and colocalization experiments was determined using an unpaired two-tailed
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